Los topics para esta convocatoria son:
Topic 1: Patient perspective elicitation on benefits and risks of medicinal products, from development through the entire life cycle, to inform the decision-making process by regulators and health technology assessment bodies.
Topic 2: Diabetic kidney disease biomarkers (DKD-BM).
Topic 3: Inflammation and AD: modulating microglia function - focussing on TREM2 and CD33.
Topic 4: Understanding the role of amyloid imaging biomarkers in the current and future diagnosis and management of patients across the spectrum of cognitive impairment (from pre-dementia to dementia).
Topic 5: Evolving models of patient engagement and access for earlier identification of Alzheimer's disease: phased expansion study. / Topic 6: From ApoE biology to validated Alzheimer's disease targets.
Dotación económica: Según topic. Hasta el 100% de los costes elegibles. Costes indirectos: 25%.
Vetinnova © 2024